Aytu appoints Jonathan Heath McGrael VP of sales

Aytu appoints Jonathan Heath McGrael VP of sales

ENGLEWOOD-- Aytu BioScience Inc . (OTCQB: AYTU), a specialty health care company developing treatments for urological and related conditions, announced the appointment of Jonathan Heath McGrael ... Read More

Thursday September 10, 2015 0 comments Tags: Englewood, Aytu BioScience, Jonathan Heath McGra, Josh Disbrow, ProstaScint